Evidence-based recommendations on delgocitinib (Anzupgo) for treating moderate to severe chronic hand eczema in adults when topical corticosteroids have not worked or are not suitable. There is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback